BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18319307)

  • 1. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
    Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
    J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients.
    Soardi FC; Barbaro M; Lau IF; Lemos-Marini SH; Baptista MT; Guerra-Junior G; Wedell A; Lajic S; de Mello MP
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2416-20. PubMed ID: 18381579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.
    Tardy V; Menassa R; Sulmont V; Lienhardt-Roussie A; Lecointre C; Brauner R; David M; Morel Y
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1288-300. PubMed ID: 20080860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia.
    Dracopoulou-Vabouli M; Maniati-Christidi M; Dacou-Voutetakis C
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2845-8. PubMed ID: 11397897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
    Liao XY; Zhang YF; Gu XF
    Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.
    Krone N; Braun A; Roscher AA; Knorr D; Schwarz HP
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1059-65. PubMed ID: 10720040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
    Riepe FG; Hiort O; Grötzinger J; Sippell WG; Krone N; Holterhus PM
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2891-5. PubMed ID: 18445671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions in the CYP21A2 promoter explain the simple-virilizing form of 21-hydroxylase deficiency in patients harbouring a P30L mutation.
    Araujo RS; Billerbeck AE; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):132-6. PubMed ID: 15670187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia.
    Robins T; Bellanne-Chantelot C; Barbaro M; Cabrol S; Wedell A; Lajic S
    J Mol Med (Berl); 2007 Mar; 85(3):247-55. PubMed ID: 17119906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
    Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
    Grigorescu Sido A; Weber MM; Grigorescu Sido P; Clausmeyer S; Heinrich U; Schulze E
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5769-73. PubMed ID: 16046588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.
    Stikkelbroeck NM; Hoefsloot LH; de Wijs IJ; Otten BJ; Hermus AR; Sistermans EA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3852-9. PubMed ID: 12915679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
    Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
    Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
    Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
    Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in steroid 21-hydroxylase (CYP21).
    White PC; Tusie-Luna MT; New MI; Speiser PW
    Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common CYP21 gene mutations in Czech patients and statistical analysis of worldwide mutation distribution.
    Kotaska K; Lisá L; Průsa R
    Cent Eur J Public Health; 2003 Sep; 11(3):124-8. PubMed ID: 14514162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region.
    Balsamo A; Cacciari E; Baldazzi L; Tartaglia L; Cassio A; Mantovani V; Piazzi S; Cicognani A; Pirazzoli P; Mainetti B; Zappulla F
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):117-25. PubMed ID: 10931088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular characterization of mutations and phenotype/genotype correlation in Chinese patients with 21-hydroxylase deficiency].
    Zhang B; Lu ZL; Wang Y; Tao H
    Yi Chuan Xue Bao; 2004 Sep; 31(9):950-5. PubMed ID: 15493145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated p.H62L Mutation in the CYP21A2 Gene in a Simple Virilizing 21-Hydroxylase Deficient Patient.
    Taboas M; Fernández C; Belli S; Buzzalino N; Alba L; Dain L
    Case Rep Genet; 2013; 2013():143781. PubMed ID: 23936690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.